Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00277-017-3023-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Low-level somatic V617F mutation in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts, and thrombocytosis with co-mutated and .
Blood Res
September 2022
Department of Laboratory Medicine and Genetics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
Primary myelofibrosis with concurrent and mutations: A case report.
World J Clin Cases
November 2020
Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, Zhejiang Province, China.
Background: Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN) characterized by recurrent mutations in the , , and genes. The and co-mutation is very rare. To our knowledge, no more than five cases have been reported.
View Article and Find Full Text PDFCo-mutated CALR and MPL driver genes in a patient with myeloproliferative neoplasm.
Ann Hematol
August 2017
UGC de Hematología, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory.
Ann Hematol
May 2017
Division of Cancer Medicine, Department of Pathology, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Australia.
Mutations in CALR have recently been detected in JAK2-negative myeloproliferative neoplasms (MPNs) and are key pathological drivers in these diseases. CALR-mutated MPNs are shown to have numerous clinicopathological differences to JAK2-mutated MPNs. The basis of these differences is poorly understood.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!